Alpine Immune Sciences Q3 2023 EPS $(0.24) Up From $(0.42) YoY, Revenue $10.043M Beats $7.249M Estimate
Portfolio Pulse from Benzinga Newsdesk
Alpine Immune Sciences reported an improvement in its Q3 2023 earnings per share (EPS) to $(0.24) from $(0.42) in the same quarter the previous year. The company's revenue of $10.043 million also surpassed the estimate of $7.249 million.
November 14, 2023 | 10:12 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Alpine Immune Sciences reported a significant year-over-year improvement in Q3 2023 EPS and exceeded revenue estimates, indicating a positive financial performance.
The improvement in EPS and revenue beat are strong indicators of Alpine Immune Sciences' financial health and operational performance. This positive earnings report is likely to instill investor confidence and could lead to a short-term uptick in ALPN's stock price.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100